naltrexone in obsessive-compulsive disorder: an open- label trial

Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial.

Obsessive Compulsive Disorder in Adolescents

Background: Obsessive-compulsive disorder (OCD) is a common psychological disorder with a high rate of incidence reported in adolescents. This disorder causes many social and economic costs for the affected people and the society as well as affecting the social, educational and occupational performance of these adolescents. Method: Some papers on obsessive-compulsive disorder in adolescents in...

Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: an open trial.

This work aims is to evaluate the therapeutic efficacy of cognitive behavior therapy (CBT) in pediatric patients with obsessive-compulsive disorder (OCD) who had not previously been treated with either pharmacotherapy or psychotherapy and who remained medication-free during CBT. Sixteen OCD outpatients, 8-17 years of age, were treated in a 12-week open trial with manualized CBT. Target symptoms...

Inositol augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: an open trial.

Inositol, an isomer of glucose and precursor in the phosphatidylinositol cycle, may be effective in a number of psychiatric disorders, including obsessive-compulsive disorder (OCD). There is little data, however, on inositol as an augmenting agent of serotonin reuptake inhibitors (SRIs) in treatment-refractory patients. Ten OCD patients who had failed to respond to current and previous trials o...

Atomoxetine Induced Obsessive-Compulsive Disorder

Introduction: Attention deficit and hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children and adolescents. Atomoxetine is a non-stimulant drug used in the treatment of ADHD. Case Presentation: In this article, a case of obsessive-compulsive disorder (OCD) which occurred in an 11-year-old boy with an increased dose of atomoxetin...

An open trial of videoconference-mediated exposure and ritual prevention for obsessive-compulsive disorder.

The gold-standard treatment for OCD is exposure and ritual prevention (ERP), yet despite its well-established efficacy, only a small percentage of OCD patients have access to this treatment. Remote treatments (e.g., videoconferencing) are becoming increasingly popular avenues for treatment delivery and show promise in increasing patient access to evidence-based mental health care. The current p...